CHE vs TECH
Chemed Corp (CHE) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Chemed Corp (CHE) is a medical care facilities company listed on NYSE.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported CHE revenue for 2024-12-31 was $2.43B. Net income was $302.0M. Revenue was up 7.4% from 2023-12-31 to 2024-12-31. CHE currently screens at market cap $5.79B and trailing P/E 23.8.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
CHE currently screens at market cap $5.79B and trailing P/E 23.8. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the CHE and TECH stock pages for the full models.
Not investment advice.